Fludarabine phosphate(Cas: 75607-67-9)
You May Also Be Interested In:
Specifications: White crystal powder; Anticancer pharmaceutical medicines--API
Quality: HPLC: 98% min
FDA site inspection approval, zero 483 observation. US DMF USP EP BP
FLUDARA FOR INJECTION is indicated for the treatment of adult patients with B-cell chronic lymphocytic leukemia(CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen. The safetandeffectiveness of FLUDARA FOR INJECTION in previously untreated or non-refractory patients with CLL have not been established.